SCHEMBL7898573

SCHEMBL7898573

NC(CC1CCCCCC1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.46
METAP1 P53582 1/20 0.46
IDO1 P14902 2/20 0.44
GAA P10253 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
BCHE P06276 3/20 0.41
CCR1 P32246 1/20 0.40
SCN4A P35499 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28660567 1.00 METAP2 (0.46) METAP2METAP1IDO1GAAL3MBTL1
SCHEMBL12927229 1.00 METAP2 (0.46) METAP2METAP1IDO1GAAL3MBTL1
SCHEMBL28672429 1.00 METAP2 (0.46) METAP2METAP1IDO1GAAL3MBTL1
SCHEMBL9009370 1.00 METAP2 (0.46) METAP2METAP1IDO1GAAL3MBTL1
Hydrochloric Acid SCHEMBL9009360 0.98 IDO1 (0.46) METAP2METAP1IDO1GAAL3MBTL1
SCHEMBL10349212 0.98 METAP2 (0.43) METAP2METAP1IDO1GAAL3MBTL1
SCHEMBL6854233 0.90 SCN4A (0.44) IDO1SCN4A
SCHEMBL3061093 0.90 SCN4A (0.44) IDO1SCN4A
SCHEMBL5455701 0.90 SCN4A (0.44) IDO1SCN4A
SCHEMBL17892144 0.87 CHRNB2 (0.43) METAP2METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE37035-E1 HYPOGLYCEMIC AGENTS BOEHRINGER INGELHEIM KG (DE) 2001-01-30 US disclosed
US-6143769-A ENANTIOMORPH KARL THOMAE GMBH (DE) 2000-11-07 US disclosed
US-5312924-A Compounds for lowering blood sugar and effecting metabolism DR. KARL THOMAE GMBH (DE) 1994-05-17 US disclosed
US-5216167-A Hypoglycemic agents DR. KARL THOMAE GMBH (DE) 1993-06-01 US disclosed
EP-0208200-A1 Phenylacetic-acid derivatives, pharmaceutical compositions containing them and processes for their production Dr. Karl Thomae GmbH (DE) 1987-01-14 EP disclosed